Haplotype analysis of the prostacyclin synthase gene and essential hypertension
- PMID: 12924623
- DOI: 10.1291/hypres.26.553
Haplotype analysis of the prostacyclin synthase gene and essential hypertension
Abstract
Previously, we discovered 3 polymorphisms in the prostacyclin synthase (PGIS) gene: 1) T-192G, in the 5-flanking region, a novel single-nucleotide polymorphism (SNP) that is not associated with essential hypertension (EH); 2) a variable number of tandem repeat (VNTR) polymorphism, 6 nucleotides upstream from the ATG start codon, that is associated with risk of cerebral infarction; and 3) C1117A, in exon 8, an SNP that does not cause an amino acid change in codon 373, and that is associated with risk of myocardial infarction (MI). The purpose of the present study was to establish haplotypes of the PGIS gene consisting of these 3 polymorphisms, and to assess the association between these haplotypes and EH. We detected 19 haplotypes. There was no significant difference in the overall distribution of haplotypes between EH and normotensive subjects. To summarize, we successfully identified haplotypes of the PGIS gene, and these haplotypes were not associated with EH.
Similar articles
-
Association study between a novel single nucleotide polymorphism of the promoter region of the prostacyclin synthase gene and essential hypertension.Hypertens Res. 2002 Jan;25(1):65-8. doi: 10.1291/hypres.25.65. Hypertens Res. 2002. PMID: 11924728
-
Polymorphism of the promoter region of prostacyclin synthase gene is not related to essential hypertension.Am J Hypertens. 2001 May;14(5 Pt 1):409-11. doi: 10.1016/s0895-7061(00)01256-5. Am J Hypertens. 2001. PMID: 11368458
-
Polymorphism of the promoter region of prostacyclin synthase gene in chronic thromboembolic pulmonary hypertension.Respirology. 2004 Jun;9(2):184-9. doi: 10.1111/j.1440-1843.2004.00568.x. Respirology. 2004. PMID: 15182267
-
Prostacyclin synthase gene: genetic polymorphisms and prevention of some cardiovascular diseases.Curr Med Chem Cardiovasc Hematol Agents. 2005 Apr;3(2):157-64. doi: 10.2174/1568016053544327. Curr Med Chem Cardiovasc Hematol Agents. 2005. PMID: 15853702 Review.
-
[Prostacyclin synthase gene; nonsense mutation and the gene therapy].Nihon Rinsho. 2000 Feb;58 Suppl 2:696-9. Nihon Rinsho. 2000. PMID: 11028431 Review. Japanese. No abstract available.
Cited by
-
Association study: the aminopeptidase a gene and essential hypertension.Int J Biomed Sci. 2005 Jun;1(1):16-22. Int J Biomed Sci. 2005. PMID: 23674950 Free PMC article.
-
Altered Expression of Long Noncoding RNAs in Blood After Ischemic Stroke and Proximity to Putative Stroke Risk Loci.Stroke. 2016 Dec;47(12):2896-2903. doi: 10.1161/STROKEAHA.116.013869. Epub 2016 Nov 10. Stroke. 2016. PMID: 27834745 Free PMC article.
-
Haplotype Based Association Study between t-PA Gene and Essential Hypertension.Int J Biomed Sci. 2006 Jun;2(2):166-71. Int J Biomed Sci. 2006. PMID: 23674978 Free PMC article.
-
Association study of aromatase gene (CYP19A1) in essential hypertension.Int J Med Sci. 2008 Feb 7;5(1):29-35. doi: 10.7150/ijms.5.29. Int J Med Sci. 2008. PMID: 18274619 Free PMC article.
-
International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.Pharmacol Rev. 2020 Oct;72(4):910-968. doi: 10.1124/pr.120.019331. Pharmacol Rev. 2020. PMID: 32962984 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical